Tirzepatide Weight Loss in Dallas, TX

Our Dallas weight loss clinic prescribes tirzepatide (Mounjaro, Zepbound) for qualifying patients. Dual-action GLP-1/GIP medication with the strongest clinical weight loss data available.

About Tirzepatide

What Is Tirzepatide for Weight Loss?

Tirzepatide is an FDA-approved dual-action injectable that targets both GLP-1 and GIP receptors. It is the first medication in its class to work on two appetite-regulating hormones at once. Brand names include Mounjaro (approved for type 2 diabetes) and Zepbound (approved for weight loss).

Clinical trials showed tirzepatide produces more weight loss than semaglutide on average. Patients lost up to 22.5% of their body weight over 72 weeks in the SURMOUNT-1 trial.

At our Dallas weight loss clinic, tirzepatide is prescribed after a full medical evaluation. Your weight loss doctor reviews your lab work, BMI, health history, and insurance coverage to determine if tirzepatide is the right fit.

Clinician preparing a tirzepatide injection pen on a sterile tray in a clinic

Tirzepatide Clinical Data

Tirzepatide Weight Loss Results

Tirzepatide has produced the strongest weight loss results of any GLP-1 medication in clinical trials to date.

~22%

Average body weight lost at the highest dose in the SURMOUNT-1 trial

Dual

Acts on both GLP-1 and GIP receptors for stronger appetite control

Weekly injection, self-administered at home

Tirzepatide vs Semaglutide

How Tirzepatide Compares to Semaglutide

Both medications are effective for weight loss. Your Dallas weight loss doctor will recommend the best option based on your labs, insurance, and clinical profile.

Feature	Tirzepatide	Semaglutide
Mechanism	Dual GLP-1 + GIP	GLP-1 only
Average weight loss	Up to 22.5%	Up to 15%
Brand (weight loss)	Zepbound	Wegovy
Brand (diabetes)	Mounjaro	Ozempic
Dosing	Once weekly	Once weekly
FDA approved for weight loss	Yes (Zepbound)	Yes (Wegovy)

Who Qualifies

Are You a Candidate for Tirzepatide in Dallas?

Candidacy requirements for tirzepatide are similar to semaglutide. Our weight loss doctor evaluates each patient individually.

BMI of 30 or higher, or BMI of 27+ with a weight-related condition
Lab work and full medical evaluation required before prescribing
No history of medullary thyroid carcinoma or MEN2
Common side effects include nausea, diarrhea, and decreased appetite

Tirzepatide Weight Loss FAQs

Common questions about tirzepatide treatment at our Dallas clinic.

Clinical trials show tirzepatide produces greater average weight loss than semaglutide. The SURMOUNT trials showed up to 22.5% body weight loss compared to about 15% for semaglutide. That said, individual responses vary, and insurance coverage often determines which medication is prescribed first. Your weight loss doctor will help you choose.

Zepbound (tirzepatide for weight loss) is covered by some insurance plans. Mounjaro is more commonly covered when prescribed for type 2 diabetes. We offer free insurance verification and also have compounded tirzepatide and self-pay options.

The most common side effects are nausea, diarrhea, decreased appetite, vomiting, and constipation. These are usually mild and decrease over time as your body adjusts. We start at a low dose and increase gradually. Your weight loss doctor monitors side effects at every visit.

Both contain tirzepatide. Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight loss. They contain the same active ingredient. Your physician will prescribe the appropriate brand based on your diagnosis and insurance coverage.

Schedule a Free Consultation at Our Dallas Weight Loss Clinic

Your first visit is free. Our weight loss doctors will review your health history, discuss your goals, and explain which treatment options fit your situation.

Request Your Free Consultation

Fill out this form and our patient coordinator will call you within one business day.